024: Identifying epigenetic markers predicting response to inhibition of CD95 signaling in glioblastoma

HIPO Investigator:

Prof. Wick

Prof. Wiestler

Supported by: POP

Entity: glioma

Publications:

Wick et al.; A phase II, randomized, study of weekly APG101+reirradiation versus reirradiation in progressive glioblastoma, Clin Cancer Res 2014

Wiestler B et al.; Integrated DNA methylation and copy-number profiling identify three clinically and biologically relevant groups of anaplastic glioma, Acta Neuropathol. 2014

 

DKFZ Logo 3zu Research en Black Blue sRGB

4c nctlogo 2009

Cookies make it easier for us to provide you with our services. With the usage of our services you permit us to use cookies.
More information Ok Decline